NCT04645303

Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger

Name: Clinical Trial NCT04645303
Creator: Dubai Health Authority
Keywords: Trigger Finger, hyaluronic acid (20 mg/2 mL), Early Phase 1, drug, clinical trial, United Arab Emirates

Ultrasound-Guided Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger: Randomized Controlled Study

Dubai Health Authority·Early Phase 1·ClinicalTrials.gov·drugRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Trigger Finger
Drug/Device/Intervention: hyaluronic acid (20 mg/2 mL)
Study type: Interventional
Intervention type: drug

Sponsor & location

Primary sponsor: Dubai Health Authority
Location: Dubai, United Arab Emirates

Timeline & enrollment

Phase: Early Phase 1
Start date: Nov 06, 2020
End date: Jun 04, 2021
Enrollment: 100 participants

Primary outcome

Change in Quinnell trigger finger grading system:

Summary

The aim of the study is to compare the therapeutic effects of hyaluronic acid versus steroid injections in treating trigger fingers using ultrasound guidance

ICD-10 classifications

Trigger fingerAccessory finger(s)Fused fingersAccessory thumb(s)Clubbing of fingers

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT04645303
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT04645303 through Pure Global AI's free database. This Early Phase 1 trial is sponsored by Dubai Health Authority and is currently Recruiting. The study focuses on Trigger Finger. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.